You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CPD

Advances in the Management of MS: A Reappraisal of Disease Progression and Treatment Strategies

  • Authors: Jiwon Oh, MD, PhD, FRCPC; Amit Bar-Or, MD, FRCPC; Virginia Devonshire, MD, FRCPC
  • CPD Released: 12/14/2020
  • THIS ACTIVITY HAS EXPIRED
  • Valid for credit through: 12/14/2021
Start Activity


Target Audience and Goal Statement

This educational activity is intended for an international audience of non-US neurologists and nurses practicing in Canada.

The goal of this activity is to improve clinician knowledge regarding recent advances in managing multiple sclerosis (MS), new evidence about the pathophysiology of MS progression, the rationale and emerging data concerning B-cell-targeted therapies, and updated guidelines for managing MS.

Upon completion of this activity, participants will be able to:

  • Describe evidence supporting the progressive nature of MS
  • Discuss key clinical outcomes with B cell-targeting therapies in MS
  • Analyze evidence supporting the use of intensive treatment early in the disease course
  • Apply guideline recommendations that can be used to inform the treatment decision making process


Disclosures

WebMD Global requires each individual who is in a position to control the content of one of its educational activities to disclose any relevant financial relationships occurring within the past 12 months that could create a conflict of interest.


Steering Committee and Faculty

  • Jiwon Oh, MD, PhD, FRCPC

    Assistant Professor
    Division of Neurology
    St. Michael's Hospital
    University of Toronto
    Toronto, Ontario, Canada

    Disclosures

    Disclosure: Jiwon Oh, MD, PhD, FRCPC, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Alexion; Biogen Idec; Bristol Myers Squibb; EMD Serono; Novartis; Roche; Sanofi-Genzyme
    Received grants for clinical research from: Biogen Idec; EMD Serono; Roche

  • Amit Bar-Or, MD, FRCPC

    Professor
    Department of Neurology
    University of Pennsylvania
    Philadelphia, Pennsylvania, United States

    Disclosures

    Disclosure: Amit Bar-Or, MD, FRCPC, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Atara Biotherapeutics; Biogen Idec; Bristol Myers Squibb; Janssen/Actelion; Medimmune; Merck/EMD Serono; Novartis; Roche/Genentech; Sanofi-Genzyme
    Received grants for clinical research from: Biogen Idec; Merck/EMD Serono; Novartis; Roche-Genentech

  • Virginia Devonshire, MD, FRCPC

    Clinical Associate Professor
    Division of Neurology
    University of British Columbia
    UBC Hospital
    Vancouver, British Columbia, Canada

    Disclosures

    Disclosure: Virginia Devonshire, MD, FRCPC, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Alexion; Biogen; Novartis; Roche; Sanofi Genzyme; Serono; Teva Neurosciences
    Served as a speaker or a member of a speakers bureau for: Alexion; Biogen; Novartis; Roche; Sanofi Genzyme; Serono; Teva Neurosciences

Editors

  • Leanne Fairley, BJ Hon

    Medical Education Director, WebMD Global, LLC

    Disclosures

    Disclosure: Leanne Fairley, BJ Hon, has disclosed no relevant financial relationships.

  • Christin Melton, ELS

    Scientific Content Manager, Medscape, LLC

    Disclosures

    Disclosure: Christin Melton, ELS, has disclosed no relevant financial relationships.

Content Reviewer

  • Amy Bernard, MS, BSN, RN-BC, CHCP

    Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Disclosure: Amy Bernard, MS, BSN, RN-BC, CHCP, has disclosed no relevant financial relationships.


Accreditation Statements

This program was co-developed by the Canadian Neurological Sciences Federation and WebMD Global, with the support of Hoffmann-La Roche Limited and was planned to achieve scientific integrity, objectivity and balance. 

    For Physicians

  • This program is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification program of the Royal College of Physicians and Surgeons of Canada, and approved by the Canadian Neurological Sciences Federation for 1.25 credits. This webinar was co-developed by the Canadian Neurological Sciences Federation and WebMD Global and was planned to achieve scientific integrity, objectivity and balance.  The Webinar was supported by Hoffmann-La Roche Limited who provided an unrestricted educational grant.

    Contact WebMD Global

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information about your eligibility to claim credit, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent participating in the activity. To successfully earn credit, participants must complete the activity online during the credit eligibility period that is noted on the title page.

Follow these steps to claim a credit certificate for completing this activity:

  1. Read the information provided on the title page regarding the target audience, learning objectives, and author disclosures, read and study the activity content and then complete the post-test questions. If you earn a passing score on the post-test and we have determined based on your registration profile that you may be eligible to claim CPD credit for completing this activity, we will issue you a CPD credit certificate.
  2. Once your CPD credit certificate has been issued, you may view and print the certificate from your CME/CE Tracker. CPD credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of the Medscape Education homepage.

We encourage you to complete an Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.

*The credit that you receive is based on your user profile.

CPD

Advances in the Management of MS: A Reappraisal of Disease Progression and Treatment Strategies

Authors: Jiwon Oh, MD, PhD, FRCPC; Amit Bar-Or, MD, FRCPC; Virginia Devonshire, MD, FRCPCFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED

CPD Released: 12/14/2020

Valid for credit through: 12/14/2021

processing....

Contents of This CPD Activity

All sections of this activity are required for credit.

Current Unmet Needs and Open Questions in the Management of Progression in MS

What do we still need to know about monitoring, diagnosing, and managing progression in MS?
Jiwon Oh, MD, PhD, FRCPC

Understanding Disease Progression in MS: Looking Across the Disease Continuum

What role do B cells play in the pathophysiology of progression in MS?
Amit Bar-Or, MD, FRCPC

Emerging Imaging Markers of Disease Progression and Recent Advances in the Therapeutic Landscape and Clinical Trials in MS

Are you using the most effective pharmacological treatments for your patients with MS?
Jiwon Oh, MD, PhD, FRCPC

Current Guideline Recommendations for Treatment Initiation and Optimization in MS

What’s new from the Canadian MS Working Group’s guidelines for managing MS?
Virginia Devonshire, MD, FRCPC

Putting the Recommendations Into Practice: Patient Cases

How would you manage these challenging cases of patients with MS?
Jiwon Oh, MD, PhD, FRCPC; Virginia Devonshire, MD, FRCPC
 
  • Print